Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Jins Holdings Inc. (3046:JPX), powered by AI.
Jins Holdings Inc. is currently trading at ¥8,560. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Jins Holdings Inc. on Alpha Lenz.
Jins Holdings Inc.'s P/E ratio is 24.0.
“Jins Holdings Inc. trades at a P/E of 24.0 (fair value) with strong ROE of 29.1%. 3Y revenue CAGR of 13.3% highlights clear growth momentum.”
Ask for details →Jins Holdings Inc. is a prominent eyewear company headquartered in Tokyo, Japan, known for its innovative approach to designing and retailing optical products. The primary function of Jins Holdings is to provide a wide range of eyewear options, including prescription glasses and sunglasses, that blend functionality with style. Their commitment to quality and fashion-forward designs has positioned them as a leading player in the eyewear industry. Jins Holdings is particularly notable for its use of advanced technology in eyewear production, including glasses that protect against digital eye strain and tailored-fit production using AI and digital solutions. The corporation impacts sectors such as retail and fashion, bringing to the market an array of products that cater to differing consumer needs and preferences. In the financial market, Jins Holdings Inc. has marked its presence as a solid performer within the consumer goods sector, reflecting its robust business model and growth in both domestic and international markets. The company's continuous innovation and expansion strategy demonstrate its pivotal role in shaping eyewear retail's current and future landscape.
“Jins Holdings Inc. trades at a P/E of 24.0 (fair value) with strong ROE of 29.1%. 3Y revenue CAGR of 13.3% highlights clear growth momentum.”
Ask for details →Jins Holdings Inc. (ticker: 3046) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 3,485 employees. Market cap is $199.8B.
The current price is 8,560 with a P/E ratio of 23.99x and P/B of 6.29x.
ROE is 29.06% and operating margin is 12.44%. Annual revenue is $97.2B.